DSM in exclusive discussions to acquire Aland (China)
09 4월 2014 - 3:15PM
Royal DSM,
the global Life Sciences and Materials
Sciences company, announces today it
is in exclusive discussions with Aland Nutraceutical Holding, Ltd.
("Aland") that may or may not result in the acquisition of Aland, a
China-based global producer of vitamin C. Further information will
be announced in due course, if and when appropriate.
If successful, this relatively small acquisition
would allow DSM to further strengthen its position in vitamin C.
For DSM the acquisition, which would fully meet its financial and
strategic requirements, would add to its position in vitamin C, the
world's largest vitamin measured by volume. Aland would also
improve DSM's global footprint in vitamins for Human Nutrition
& Health, Animal Nutrition & Health and Personal Care, as
it adds to DSM's existing vitamin C capacity in Dalry (Scotland,
United Kingdom) to which the company remains fully committed.
Aland was founded in 1990 and has a production
facility in the Jiangsu Province in China. In 2013 the company
realized net sales of about USD 90 million in vitamin C.
Vitamin C is an essential health ingredient that
the body cannot produce itself and that needs to be absorbed
through diet or supplementation. Vitamin C is widely found in
fruits and vegetables. The recommended dietary allowances for
vitamin C in the United States were recently revised upwards to 90
mg/day for men and 75 mg/day for women.
DSM - Bright Science.
Brighter Living.(TM)
Royal DSM is a global science-based company active in health,
nutrition and materials. By connecting its unique competences in
Life Sciences and Materials Sciences DSM is driving economic
prosperity, environmental progress and social advances to create
sustainable value for all stakeholders simultaneously. DSM delivers
innovative solutions that nourish, protect and improve performance
in global markets such as food and dietary supplements, personal
care, feed, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based
materials. DSM's 24,500 employees deliver annual net sales of
around €10 billion. The company is listed on NYSE Euronext. More
information can be found at www.dsm.com.
Or find us on:
For more
information:
DSM
Corporate Communications Herman Betten
tel. +31 (0) 45
5782017
e-mail media.contacts@dsm.com |
DSM
Investor Relations Dave Huizing
tel. +31 (0) 45 5782864
e-mail investor.relations@dsm.com |
Press release-pdf
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: DSM N.V. via Globenewswire
HUG#1775460
Royal DSM NV (QX) (USOTC:RDSMY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Royal DSM NV (QX) (USOTC:RDSMY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024